Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydrogenolysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113264908B reveals a green heterogeneous catalytic route for 3-hydroxytetrahydrofuran, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN106905137A details a high-yield valeric acid synthesis from biomass. Discover cost-effective, eco-friendly manufacturing solutions for global supply chains.
Patent CN102260298A reveals a high-yield synthesis route for 1,2,3-O-triacetyl-5-deoxy-beta-D-ribose, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN1228341C details a novel camptothecin synthesis from 9-methoxycamptothecin, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN102206164A details a cleaner route for Tapentadol intermediates using PCl5 and catalytic hydrogenation, offering significant cost and safety advantages for API manufacturing.
Advanced chemical synthesis of Quercetin-3-O-acyl esters via patented benzylation and esterification routes. Offers superior bioavailability and scalable manufacturing for pharmaceutical applications.
Discover the novel 5-step synthesis for Roflumilast intermediate I. Enhanced yield, no chromatography, and scalable industrial production for global supply chains.
Patent CN107674017A details a two-step catalytic hydrogenolysis route for high-purity light stabilizer intermediates, offering significant cost reduction and scalable supply chain reliability for polymer additive manufacturing.
Novel route for diethyl p-methylaminobenzoyl-L-glutamate avoids autoclave, improves yield, ensures reliable supply chain for API manufacturing.
Patent CN108003141A reveals a safer alfuzosin route. Achieve cost reduction in pharmaceutical intermediates manufacturing with stable yields and scalable processes.
Novel non-hydrogenation route for Tamsulosin HCl. Eliminates heavy metals in step 1, ensuring high purity and safety for API manufacturing.
Novel antitumor intermediates via efficient peptide coupling and hydrogenolysis offering scalable supply chain solutions for pharmaceutical development and significant cost reduction in manufacturing.
Novel process for alpha-2 antagonist intermediates avoiding formamide. High yield, scalable route for cognitive disorder drug candidates.
Patent CN1466560A reveals a scalable hydrogenolysis process for fluorinated methyl-benzyl alcohol, offering significant cost reduction and supply chain reliability for agrochemical intermediates.
Patent CN104418775B details palladium-catalyzed asymmetric hydrogenolysis for high-purity chiral amine production offering significant supply chain and cost advantages.
Advanced preparation method of Ivermectin utilizing Avermectin B2. Enhances yield to 72% while eliminating toxic tributyltin reagents for cost-effective manufacturing.
Patent CN115677546B reveals a novel chiral synthesis route for Florfenicol intermediates, offering higher yields and eliminating toxic copper waste for reliable supply chains.
Novel Teoc protection route for Dipeptide-2 offers scalable production and cost efficiency for cosmetic ingredient supply chains globally.
Patent CN107673978A reveals high yield synthesis route. Offers cost reduction and scalable supply chain for pharmaceutical intermediate manufacturing globally.
Efficient catalytic hydrogenolysis route for high-purity agrochemical intermediates. Reduces steps and cost for chrysanthemic acid derivatives manufacturing.